Europe PMCopen access
Current landscape and emerging trends of PD-1/PD-L1 research in prostate cancer: A data-driven atlas from multidatabase integration
Immunotherapy, prostate cancer, Tumor Microenvironment, Programmed Death-ligand 1, Programmed Cell Death Protein-1, Immune Checkpoint Inhibitors
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 970725
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.